A report on World Health Organization, Malaria and RTS,S
In October 2021, the vaccine was endorsed by the World Health Organization (WHO) for "broad use" in children, making it the first malaria vaccine candidate, and first vaccine to address parasitic infection, to receive this recommendation.- RTS,S
Its current priorities include communicable diseases, particularly HIV/AIDS, Ebola, COVID-19, malaria and tuberculosis; non-communicable diseases such as heart disease and cancer; healthy diet, nutrition, and food security; occupational health; and substance abuse.- World Health Organization
As of 2012, the WHO was to report as to whether RTS,S/AS01, were a viable malaria vaccine.- World Health Organization
In areas where malaria is common, the World Health Organization (WHO) recommends clinicians suspect malaria in any person who reports having fevers, or who has a current temperature above 37.5 °C without any other obvious cause.- Malaria
As of 2020, there is one vaccine for malaria (known as RTS,S) which is licensed for use.- Malaria
1 related topic with Alpha
Malaria vaccine0 links
A malaria vaccine is a vaccine that is used to prevent malaria.
The only approved vaccine, as of 2021, is RTS,S, known by the brand name Mosquirix.
It is the first vaccine that meets the World Health Organization's (WHO) goal of a malaria vaccine with at least 75% efficacy.